| |
| |
|
| Insider
Information: |
Kolchinsky Peter |
| Relationship: |
Director, 10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
21 |
|
| Direct
Shares |
6,648,738 |
|
|
Indirect Shares
|
89,615,900 |
|
|
| Direct
Value |
$30,628,641 |
|
|
|
Indirect Value
|
$946,611,696 |
|
|
| Total
Shares |
96,264,638 |
|
|
| Total
Value |
$977,240,337 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 14.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALA |
Kala Pharmaceuticals, Inc... |
Director |
– • • |
2018-10-03 |
4 |
B |
$8.25 |
$19,999,997 |
I/I |
2,424,242 |
4,537,478 |
2.25 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Director |
– • • |
2020-03-13 |
4 |
B |
$7.89 |
$49,999,995 |
I/I |
6,337,135 |
10,874,613 |
2.25 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2016-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
591,070 |
591,070 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Director |
– • • |
2017-10-12 |
4 |
B |
$8.50 |
$7,225,000 |
I/I |
850,000 |
1,441,070 |
2.25 |
- |
|
| LIPD |
Lipid Sciences Inc |
10% Owner |
– – • |
2008-03-27 |
4 |
S |
$1.30 |
$11,245 |
I/I |
(8,650) |
3,705,312 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
– – • |
2016-10-31 |
4 |
B |
$13.00 |
$2,099,994 |
I/I |
161,538 |
1,351,808 |
1.5 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
– – • |
2016-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,190,270 |
1,190,270 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
– – • |
2018-02-14 |
4 |
B |
$6.00 |
$15,000,000 |
I/I |
2,500,000 |
3,851,808 |
1.5 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • • |
2018-12-12 |
4 |
B |
$15.50 |
$15,600,006 |
I/I |
1,006,452 |
4,858,260 |
2.25 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Director |
– • • |
2020-04-02 |
4 |
D |
$48.00 |
$233,196,480 |
I/I |
(4,858,260) |
0 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
10% Owner |
– – • |
2019-10-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,422,312 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,626,503 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-17 |
4 |
S |
$10.21 |
$493,401 |
D/D |
(48,270) |
3,626,503 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-17 |
4 |
B |
$9.79 |
$187,895 |
D/D |
19,200 |
3,645,703 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-18 |
4 |
S |
$10.02 |
$741,498 |
D/D |
(74,035) |
3,626,503 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-19 |
4 |
S |
$9.77 |
$2,065,714 |
D/D |
(209,894) |
3,603,463 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-22 |
4 |
S |
$9.56 |
$1,065,610 |
D/D |
(111,363) |
3,492,100 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-23 |
4 |
S |
$9.37 |
$46,938 |
D/D |
(5,012) |
3,487,088 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2013-07-25 |
4 |
S |
$9.50 |
$3,582,848 |
D/D |
(368,870) |
3,118,218 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2013-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,028,362 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner. |
– – – |
2013-12-12 |
4 |
B |
$12.09 |
$116,071 |
D/D |
9,600 |
4,037,962 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner. |
– – – |
2013-12-13 |
4 |
B |
$12.09 |
$60,921 |
D/D |
5,040 |
4,043,002 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner. |
– – – |
2014-01-09 |
4 |
S |
$18.28 |
$1,329,365 |
D/D |
(72,440) |
3,970,562 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2014-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,683,002 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-05 |
4 |
B |
$18.17 |
$765,828 |
D/D |
42,000 |
3,725,002 |
2.44 |
- |
|
207 Records found
|
|
Page 5 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
